Kanabo Group (LON:KNB) Trading Down 18.2% – Here’s Why

Kanabo Group Plc (LON:KNB) shares fell 18.2% during trading on Tuesday . The company traded as low as GBX 0.90 ($0.01) and last traded at GBX 0.90 ($0.01). 137,601 shares changed hands during mid-day trading, a decline of 69% from the average session volume of 436,852 shares. The stock had previously closed at GBX 1.10 ($0.01).

Kanabo Group Stock Up 10.0 %

The company has a market capitalization of £6.96 million, a P/E ratio of -100.00 and a beta of 3.04. The company has a 50-day moving average of GBX 1.09 and a two-hundred day moving average of GBX 1.31. The company has a quick ratio of 24.36, a current ratio of 2.78 and a debt-to-equity ratio of 3.49.

Insiders Place Their Bets

In related news, insider Ian Mattioli acquired 150,000 shares of the stock in a transaction on Tuesday, August 27th. The stock was acquired at an average price of GBX 1 ($0.01) per share, for a total transaction of £1,500 ($1,898.01). Corporate insiders own 37.01% of the company’s stock.

Kanabo Group Company Profile

Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary Care segments. The company offers The GP Service, an online telehealth platform, that provides patients with video consultations, online prescriptions, and primary care services; and operates Treat It, an online clinic focused on management of chronic pain.